CRX.L Regulatory News (CRX)

8 Nov 2007 12:51

Cyprotex PLC08 November 2007 Press Release 8 November 2007 Cyprotex PLC ("Cyprotex" or "the Company") Cyprotex PLC (AIM:CRX), the drug discovery technology and information company,today announces that it has issued 18,746 new ordinary shares of 0.1p each ("newOrdinary Shares") pursuant to the exercise of options. The issue of these new Ordinary shares is subject to the new Ordinary Sharesbeing admitted to trading on AIM, application for which has been made. Tradingin the new Ordinary Shares, which will rank pari passu in all respects with theexisting ordinary shares, is expected to commence on 9 November 2007. Ends - For further information: Cyprotex PLCRobert Morrisson AtwaterChairman & Chief Executive OfficerRussell GibbsChief Financial Officeriir@cvprotex.comTel: +44 (0) 1625505100www.cvprotex.com This information is provided by RNS The company news service from the London Stock Exchange